Home Cardax Pharma

Cardax Pharma

In operation
Post-IPO Round
Small Molecule Therapy Developer

Basic Information

Cardax Pharmaceuticals Inc. is developing patented small molecule therapies for major causative factors such as oxidative stress and inflammation, including dyslipidemia, metabolic diseases, arthritis, cardiovascular diseases, hepatitis, and macular degeneration.
Cardax Pharmaceuticals Inc.
Honolulu,Hawaii,United States of America
less than 15 people
January 01, 2006
info@cardaxpharma.com